TANG Zhenhua;LI Zhunan;HUANG Yong;WANG Jinjin;HU Weiping;WAN Xiaoping. Expressions of FHIT and TSLC1 genes in cervical tissues and relationship with HPV infection[J]. , 2012, 27(2): 91-94.
[1]Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review [J]. Int J Gynecol Pathol, 1993, 12(2): 186192.[2]Steenbergen RD, Kramer D, Braakhuis BJ, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia [J]. J Natl Cancer Inst, 2004, 96(4): 294305.[3]Yoon SO. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness [J]. Hum Pathol, 2007, 38(2): 326331.[4]Murakami Y. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis [J]. Cancer Sci, 2005, 96(9): 543552.[5]Birrer MJ, Hendricks D, Farley J, et al. Abnormal Fhit expression in malignant and premalignant lesions of the cervix [J]. Cancer Res, 1999, 59(20): 52705274.[6]Syeed N, Husain SA, Sameer AS, et al. Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashimir [J]. Mutat Res, 2011, 707(12): 18.[7]Cuzick J. Human papillomavirus testing for primary cervical cancer screening [J]. JAMA, 2000, 283(1): 108109.[8]Liang QL, Chen GQ, Li ZY, et al. Function and histopathology of a cell adhesion molecule TSLC1 in cancer [J]. Cancer Invest, 2011, 29(2): 107112.